Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Tanaka

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2017
Intermittent drug holidays in fingolimod therapy for multiple sclerosisMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Corticosteroid and tacrolimus treatment in neuromyelitis optica related disordersMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Multiple Sclerosis and Related Disorders|January 23, 2018
Treatment for paraneoplastic neuromyelitis optica spectrum disorder (NMOsd): Probable effects of tocilizumab for both cancer and NMOsdMasami Tanaka, Hidetoshi Yanagida, Akio Suzumura
Rinsho Shinkeigaku = Clinical Neurology|July 9, 2011
[Evaluation of blood flow and the cross-sectional area of internal jugular vein in Japanese multiple sclerosis and neuromyelitis optica patients]Masami Tanaka, Hiroshi Uchizumi, Keiko Tanaka
European Neurology|July 11, 2009
Interferon-beta(1b) treatment in neuromyelitis opticaMasami Tanaka, Keiko Tanaka, Mika Komori
Journal of the Neurological Sciences|December 17, 2003
Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neuronsKeiko Tanaka, Xin Ding, Masami Tanaka
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2013
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropeniaMasami Tanaka, Kwiyoung Park, Keiko Tanaka
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 5, 2026
T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 <sup>+</sup> CD20<sup>+</sup> cellsMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Juntendo Iji Zasshi = Juntendo Medical Journal|November 15, 2024
Effects of Fasting on Metabolic Hormones and Functions: A Narrative ReviewJulius Fink, Masami Tanaka, Shigeo Horie
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 11, 2015
Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese populationMasako Kinoshita, Kaoru Obata, Masami Tanaka
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2017
Intermittent drug holidays in fingolimod therapy for multiple sclerosisMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2015
Corticosteroid and tacrolimus treatment in neuromyelitis optica related disordersMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Multiple Sclerosis and Related Disorders|January 23, 2018
Treatment for paraneoplastic neuromyelitis optica spectrum disorder (NMOsd): Probable effects of tocilizumab for both cancer and NMOsdMasami Tanaka, Hidetoshi Yanagida, Akio Suzumura
Rinsho Shinkeigaku = Clinical Neurology|July 9, 2011
[Evaluation of blood flow and the cross-sectional area of internal jugular vein in Japanese multiple sclerosis and neuromyelitis optica patients]Masami Tanaka, Hiroshi Uchizumi, Keiko Tanaka
European Neurology|July 11, 2009
Interferon-beta(1b) treatment in neuromyelitis opticaMasami Tanaka, Keiko Tanaka, Mika Komori
Journal of the Neurological Sciences|December 17, 2003
Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neuronsKeiko Tanaka, Xin Ding, Masami Tanaka
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2013
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropeniaMasami Tanaka, Kwiyoung Park, Keiko Tanaka
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 5, 2026
T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 <sup>+</sup> CD20<sup>+</sup> cellsMasami Tanaka, Masako Kinoshita, Keiko Tanaka
Juntendo Iji Zasshi = Juntendo Medical Journal|November 15, 2024
Effects of Fasting on Metabolic Hormones and Functions: A Narrative ReviewJulius Fink, Masami Tanaka, Shigeo Horie
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 11, 2015
Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese populationMasako Kinoshita, Kaoru Obata, Masami Tanaka
Pageof 27